Merck KGaA (MER)
SIX
Closed
Aug 21, 2026
Day's Range
130.5052 wk Range
96.66Overview - MER - Merck KGaA
Key Statistics
Valuation
Enterprise Value
59.46B
P/E (Trailing)
‪23.06‬
Price / Sales (TTM)
‪2.57‬
Price / Book
‪1.92‬
EV / EBITDA
‪11.38‬
Profitability
Gross Margin
‪59.70%‬
Profit Margin
‪11.21%‬
Operating Margin
‪13.85%‬
Return on Assets
‪4.65%‬
Return on Equity
‪8.13%‬
Ownership
Shares Outstanding
434.77M
Float
128.87M
Held by Insiders
‪0.00%‬
Held by Institutions
‪55.93%‬
Price stats
Beta
‪0.80‬
50-Day Avg
‪130.04‬
200-Day Avg
‪115.87‬
Dividends
Payout Ratio
‪0.00%‬
Market Cap - MER - Merck KGaA
Peers - MER - Merck KGaA
Peer Comparison
Compared with companies in Drug Manufacturers - Specialty & Generic listed on SIX.
Profile Summary - MER - Merck KGaA
About
Merck KGaA is a science and technology company headquartered in Darmstadt, Germany, operating across three core business segments: Life Science, Healthcare, and Electronics. Its Life Science business supplies laboratory materials, instruments, and specialty products used in research, biopharmaceutical development, and…
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
